CoChat

Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

ETS-domain transcription factors play important roles in controlling gene expression in a variety of different contexts; however, these proteins bind to very similar sites and it is unclear how in vivo specificity is achieved. In silico analysis is unlikely to reveal specific targets for individual family members and direct experimental approaches are therefore required. Here, we take advantage of an inducible dominant-negative expression system to identify a group of novel target genes for the ETS-domain transcription factor Elk-1. Elk-1 is thought to mainly function through cooperation with a second transcription factor SRF, but the targets we identify are largely SRF-independent. Furthermore, we demonstrate that there is a high degree of overlapping, cell type-specific, target gene binding by Elk-1 and other ETS-domain transcription factors. Our results are therefore consistent with the notion that there is a high degree of functional redundancy in target gene regulation by ETS-domain transcription factors in addition to the specific target gene regulation that can be dictated through heterotypic interactions exemplified by the Elk-1-SRF complex.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkp804

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Identification of Elk-1-regulated genes. (A) Diagrammatic representation of the mode of action of Elk-En. Elk-En binds to ETS motifs within promoters and represses promoter activity. (B) Illustration of the induction regime used for sample preparation. The expression of Elk-En is stimulated by adding ponasterone A (PonA) to the EcR-293 (Elk-En) cells for 6 h. Cells were grown in the presence or absence of PonA, and either left serum starved or treated with EGF for 15 or 30 min before harvesting. (C) Cluster analysis of 877 genes, which show consistent downregulation upon PonA addition under at least one of the three experimental conditions (serum starved, 15 min EGF and 30 min EGF). Columns 1–6 show the relative expression of the groups of probesets representing each gene. Columns 7–9 represent the same data but show fold change in response due to PonA treatment. Hierarchical clustering was performed on columns 1–6. (D) Expression profiles of individual genes in cluster 3. Each gene is represented by a different coloured line. The black squares and line represents the average expression value of genes in this cluster under each of the six experimental conditions. For each gene, the mean of the probe sets across all six conditions was set as zero, and expression levels (log2) are presented relative to this value.
Figure 1. Identification of Elk-1-regulated genes. (A) Diagrammatic representation of the mode of action of Elk-En. Elk-En binds to ETS motifs within promoters and represses promoter activity. (B) Illustration of the induction regime used for sample preparation. The expression of Elk-En is stimulated by adding ponasterone A (PonA) to the EcR-293 (Elk-En) cells for 6 h. Cells were grown in the presence or absence of PonA, and either left serum starved or treated with EGF for 15 or 30 min before harvesting. (C) Cluster analysis of 877 genes, which show consistent downregulation upon PonA addition under at least one of the three experimental conditions (serum starved, 15 min EGF and 30 min EGF). Columns 1–6 show the relative expression of the groups of probesets representing each gene. Columns 7–9 represent the same data but show fold change in response due to PonA treatment. Hierarchical clustering was performed on columns 1–6. (D) Expression profiles of individual genes in cluster 3. Each gene is represented by a different coloured line. The black squares and line represents the average expression value of genes in this cluster under each of the six experimental conditions. For each gene, the mean of the probe sets across all six conditions was set as zero, and expression levels (log2) are presented relative to this value.CC BY-NC · PubMed Central
Figure 2. Elk-1 binds to cluster 3 gene promoters. (A) Elk-En down-regulates cluster 3 gene promoters. HEK293T cells were transiently transfected with a luciferase construct containing the indicated promoters and with increasing concentrations of Elk-En(WT) (0, 0.5, 5, 50 ng; increasing concentrations indicated by a triangle). The results were normalized to renilla luciferase activity, and the activity in the absence of Elk-En given the value of one. Error bars represent standard deviation calculated from three biologically independent replicates, each representing the average of two samples. (B) ChIP validation of Elk-1 binding to cluster 3 genes promoters. ChIP assay from HeLa cells using Elk-1-specific antibodies or a non-specific rabbit IgG, followed by real-time PCR. An SRF intronic region [SRF(Int3)] and the c-FOS promoter region were used as negative and positive controls respectively. Relative binding indicates percentage bound relative to input. Fold enrichment of Elk-1 over IgG control precipitation is shown above the bars. Results shown are representative of at least two independent experiments and are the average of two samples, and standard deviation. (C) Venn diagrams illustrating the overlap between cluster 3 genes and Elk-1 target genes identified by ChIP-chip analysis. As a comparison, the average overlap between the 1204 target genes associated with regions identified by ChIP-chip analysis and 1000 randomly selected groups of 77 genes is shown. (D) Motif logos of two of the top three sequence motifs discovered by Weeder in cluster 3 gene promoters. The Elk-1 binding motif identified from site selection studies (14) is shown at the bottom.
Figure 2. Elk-1 binds to cluster 3 gene promoters. (A) Elk-En down-regulates cluster 3 gene promoters. HEK293T cells were transiently transfected with a luciferase construct containing the indicated promoters and with increasing concentrations of Elk-En(WT) (0, 0.5, 5, 50 ng; increasing concentrations indicated by a triangle). The results were normalized to renilla luciferase activity, and the activity in the absence of Elk-En given the value of one. Error bars represent standard deviation calculated from three biologically independent replicates, each representing the average of two samples. (B) ChIP validation of Elk-1 binding to cluster 3 genes promoters. ChIP assay from HeLa cells using Elk-1-specific antibodies or a non-specific rabbit IgG, followed by real-time PCR. An SRF intronic region [SRF(Int3)] and the c-FOS promoter region were used as negative and positive controls respectively. Relative binding indicates percentage bound relative to input. Fold enrichment of Elk-1 over IgG control precipitation is shown above the bars. Results shown are representative of at least two independent experiments and are the average of two samples, and standard deviation. (C) Venn diagrams illustrating the overlap between cluster 3 genes and Elk-1 target genes identified by ChIP-chip analysis. As a comparison, the average overlap between the 1204 target genes associated with regions identified by ChIP-chip analysis and 1000 randomly selected groups of 77 genes is shown. (D) Motif logos of two of the top three sequence motifs discovered by Weeder in cluster 3 gene promoters. The Elk-1 binding motif identified from site selection studies (14) is shown at the bottom.CC BY-NC · PubMed Central
Figure 3. Role of SRF in cluster 3 gene regulation. (A) SRF binding to selected cluster 3 gene promoters. HeLa cells were serum starved for 24 h, followed by ChIP with SRF or non-specific rabbit IgG antibodies. ChIP DNA was subjected to qPCR. Relative binding indicates percentage binding relative to input sample. The ratio between SRF and non-specific IgG is indicated above the bars. An SRF intronic region [SRF(Int3)] and the c-FOS promoter region were used as negative and positive controls, respectively. Error bars represent standard deviation calculated from three biologically independent replicates and the average of two samples. (B) Western blot analysis of siRNA-mediated knockdown of SRF and GAPDH. (C) Quantitative RT–PCR analysis of cluster 3 genes upon SRF knockdown. HeLa cells were transfected with siRNA against SRF or GAPDH. Cells were either left in serum free medium for 48 h or treated with 20% FCS for 30 min and mRNA levels were measured. Error bars represent standard deviations calculated from three biologically independent replicates, each representing the average of two samples. Asterisks denote differences with statistical significances (*P < 0.05, **P < 0.01, ***P < 0.001) as determined by the Student t-test. (D and E) Reporter gene assays in HEK293T cells with the indicated promoter–reporter constructs and with either increasing concentrations of Elk-VP16 (0, 5, 10, 50 ng) (D) or SRF-VP16 (0, 10, 50, 100 ng) (E). Luciferase activity was measured 24 h after transfection. The results were normalized to renilla luciferase activity, and the activity in the absence of cotransfected VP16 fusion protein taken as 1. Error bars represent standard deviation calculated from three biologically independent replicates, each being the average of duplicate samples. Statistical differences between the bracketed samples were determined by Student’s t-test (* P < 0.05; **P < 0.01).
Figure 3. Role of SRF in cluster 3 gene regulation. (A) SRF binding to selected cluster 3 gene promoters. HeLa cells were serum starved for 24 h, followed by ChIP with SRF or non-specific rabbit IgG antibodies. ChIP DNA was subjected to qPCR. Relative binding indicates percentage binding relative to input sample. The ratio between SRF and non-specific IgG is indicated above the bars. An SRF intronic region [SRF(Int3)] and the c-FOS promoter region were used as negative and positive controls, respectively. Error bars represent standard deviation calculated from three biologically independent replicates and the average of two samples. (B) Western blot analysis of siRNA-mediated knockdown of SRF and GAPDH. (C) Quantitative RT–PCR analysis of cluster 3 genes upon SRF knockdown. HeLa cells were transfected with siRNA against SRF or GAPDH. Cells were either left in serum free medium for 48 h or treated with 20% FCS for 30 min and mRNA levels were measured. Error bars represent standard deviations calculated from three biologically independent replicates, each representing the average of two samples. Asterisks denote differences with statistical significances (*P < 0.05, **P < 0.01, ***P < 0.001) as determined by the Student t-test. (D and E) Reporter gene assays in HEK293T cells with the indicated promoter–reporter constructs and with either increasing concentrations of Elk-VP16 (0, 5, 10, 50 ng) (D) or SRF-VP16 (0, 10, 50, 100 ng) (E). Luciferase activity was measured 24 h after transfection. The results were normalized to renilla luciferase activity, and the activity in the absence of cotransfected VP16 fusion protein taken as 1. Error bars represent standard deviation calculated from three biologically independent replicates, each being the average of duplicate samples. Statistical differences between the bracketed samples were determined by Student’s t-test (* P < 0.05; **P < 0.01).CC BY-NC · PubMed Central
Figure 4. Redundancy of Elk-1 and SAP-1 binding to cluster 3 promoters. (A) HeLa cells were transfected with the indicated siRNAs and Elk-1 expression monitored by western analysis (left panel) and SAP-1 expression by qRT–PCR (right panel). (B and C) qPCR-ChIP analysis of SAP-1 (B) and Elk-1 (C) binding to the indicated promoters in HeLa cells. Where indicated, cells were transfected with siRNA against Elk-1, SAP-1 or GAPDH. Samples from serum-starved HeLa cells taken 48 h after transfection with the indicated siRNAs. ChIP was performed using antibodies against SAP-1 (B) or Elk-1 (C) or non-specific rabbit IgG. Note that the same IgG data are presented in (B and C) as these experiments were performed at the same time. The relative binding is the percentage binding relative to input sample. Error bars represent standard deviations calculated from two biologically independent replicates each being the average of duplicate samples. Arrows indicate the increase of Elk-1 binding to the promoters upon SAP-1 knock-down.
Figure 4. Redundancy of Elk-1 and SAP-1 binding to cluster 3 promoters. (A) HeLa cells were transfected with the indicated siRNAs and Elk-1 expression monitored by western analysis (left panel) and SAP-1 expression by qRT–PCR (right panel). (B and C) qPCR-ChIP analysis of SAP-1 (B) and Elk-1 (C) binding to the indicated promoters in HeLa cells. Where indicated, cells were transfected with siRNA against Elk-1, SAP-1 or GAPDH. Samples from serum-starved HeLa cells taken 48 h after transfection with the indicated siRNAs. ChIP was performed using antibodies against SAP-1 (B) or Elk-1 (C) or non-specific rabbit IgG. Note that the same IgG data are presented in (B and C) as these experiments were performed at the same time. The relative binding is the percentage binding relative to input sample. Error bars represent standard deviations calculated from two biologically independent replicates each being the average of duplicate samples. Arrows indicate the increase of Elk-1 binding to the promoters upon SAP-1 knock-down.CC BY-NC · PubMed Central
Figure 5. Cluster 3 gene regulation upon monocytic U937 cell differentiation. (A) Western analysis of changes in Fli-1 and Elk-1 levels upon U937 cell differentiation following PMA treatment for the indicated times. Quantification of the expression of each protein relative to the amount in undifferentiated cells (taken as 1) is shown below. (B) Reduced expression of cluster 3 genes upon monocyte differentiation. U937 cells were taken either before PMA-induced differentiation or 24 or 72 h after PMA addition. Expression levels of indicated genes were measured by quantitative RT–PCR. Error bars represent standard deviations calculated from two biologically independent replicates which are the average of two samples. (C and D) Dynamic changes in Elk-1 and Fli-1 binding to cluster 3 gene promoters upon monocyte differentiation. qPCR of ChIP DNA from undifferentiated (C) and differentiated (D) U937 cells using Elk-1 or Fli-1 specific antibodies or a non-specific total rabbit IgG (IgG). Differentiated cells were analysed 48 hrs after PMA stimulation. The relative binding is the percentage binding relative to input sample. Data are the average of at least two independent experiments and duplicate samples, ± standard deviation. (E) siRNA-mediated Elk-1 and FLI-1 depletion and cluster 3 gene expression in U937 cells. U937 cells were transfected with 3 µg of siRNA targeted against Elk-1 or FLI-1 (dark grey bars) or GAPDH (light grey bars). Cells were left for 24 h after transfection, then undifferentiated cells (0 h) were collected, and differentiated cells were created by treatment with 50 nM PMA for 3 h and left to differentiate for another 48 h. mRNA was isolated and the expression levels of indicated genes in the presence of reduced levels of Elk-1 (left) or FLI-1 (right) was analysed using qRT–PCR. Error bars represent standard deviations calculated from three biologically independent replicates and the average of two samples. (F) Venn diagrams illustrating the overlap between cluster 3 genes and GABPα target genes identified by ChIP-seq analysis (30). As a comparison, the average overlap between the 5091 target genes identified by ChIP-seq analysis and 1000 randomly selected groups of 77 genes is shown.
Figure 5. Cluster 3 gene regulation upon monocytic U937 cell differentiation. (A) Western analysis of changes in Fli-1 and Elk-1 levels upon U937 cell differentiation following PMA treatment for the indicated times. Quantification of the expression of each protein relative to the amount in undifferentiated cells (taken as 1) is shown below. (B) Reduced expression of cluster 3 genes upon monocyte differentiation. U937 cells were taken either before PMA-induced differentiation or 24 or 72 h after PMA addition. Expression levels of indicated genes were measured by quantitative RT–PCR. Error bars represent standard deviations calculated from two biologically independent replicates which are the average of two samples. (C and D) Dynamic changes in Elk-1 and Fli-1 binding to cluster 3 gene promoters upon monocyte differentiation. qPCR of ChIP DNA from undifferentiated (C) and differentiated (D) U937 cells using Elk-1 or Fli-1 specific antibodies or a non-specific total rabbit IgG (IgG). Differentiated cells were analysed 48 hrs after PMA stimulation. The relative binding is the percentage binding relative to input sample. Data are the average of at least two independent experiments and duplicate samples, ± standard deviation. (E) siRNA-mediated Elk-1 and FLI-1 depletion and cluster 3 gene expression in U937 cells. U937 cells were transfected with 3 µg of siRNA targeted against Elk-1 or FLI-1 (dark grey bars) or GAPDH (light grey bars). Cells were left for 24 h after transfection, then undifferentiated cells (0 h) were collected, and differentiated cells were created by treatment with 50 nM PMA for 3 h and left to differentiate for another 48 h. mRNA was isolated and the expression levels of indicated genes in the presence of reduced levels of Elk-1 (left) or FLI-1 (right) was analysed using qRT–PCR. Error bars represent standard deviations calculated from three biologically independent replicates and the average of two samples. (F) Venn diagrams illustrating the overlap between cluster 3 genes and GABPα target genes identified by ChIP-seq analysis (30). As a comparison, the average overlap between the 5091 target genes identified by ChIP-seq analysis and 1000 randomly selected groups of 77 genes is shown.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 43

Metadata

Authors
Boros, J., O’Donnell, A., Donaldson, I. J., Kasza, A., Zeef, L., & Sharrocks, A. D.
Affiliations
University of Manchester (GB)
Corresponding author
Sharrocks, Andrew D.
Venue
Nucleic Acids Research
Published
2009-09-29
Volume
37
Issue
22
Pages
7368-7380
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2102798463
Cited by
42
References
34
Citations by year
2025: 3 · 2024: 2 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 6
FWCI
2.15
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Jagiellonian University Repository (Jagiellonian University) (submittedVersion, other-oa)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
  • Wellcome Trust
  • Cancer Research UK
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
Elk-1, ETS transcription factors, promoter targeting, SRF, transcription factor specificity, functional redundancy, cell type-specific gene regulation, target gene regulation
MeSH terms
Binding Sites, Cell Line, Gene Expression Regulation, Humans, Promoter Regions, Genetic, Protein Structure, Tertiary, Serum Response Factor, Proto-Oncogene Proteins c-ets, ets-Domain Protein Elk-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members. https://app.cochat.ai/papers/10.1093/nar/gkp804
The paper
Boros, J., O’Donnell, A., Donaldson, I. J., Kasza, A., Zeef, L., & Sharrocks, A. D. (2009). Overlapping promoter targeting by Elk-1 and other divergent ETS-domain transcription factor family members. Nucleic Acids Research. https://doi.org/10.1093/nar/gkp804

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.